01 1Torrent Pharmaceuticals Limited
02 1VISUFARMA SpA
03 2Xeris Pharmaceuticals
01 3TABLET;ORAL
02 1Blank
01 1DISCN
02 2RX
03 1Blank
01 1Antidrasi
02 1DARANIDE
03 1KEVEYIS
04 1ORMALVI
01 1Italy
02 3USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ORMALVI
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-12-29
Application Number : 215924
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DARANIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 11366
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KEVEYIS
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2015-08-07
Application Number : 11366
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Antidrasi
Dosage Form :
Dosage Strength : 20 Cpr 50 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?